15-min delayed · Sep 4, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Innoviva Inc, 3 rate it Buy or better, 0 sit at Hold, and 1 rate it Sell or worse, a moderate buy consensus. Targets range widely, $17.00 to $46.00 (about 2.7x), a sign of real disagreement on valuation. The average target of $34.75 sits 63% above the current $21.31. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 1 to 0 over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.52 next quarter toward $2.21 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold00%
Sell125%
Strong Sell00%
Based on 4 analysts giving stock ratings to Innoviva Inc.
As of Sep, 3 of 3 firms rate INVA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
INVA EPS & revenue forecast
EPS · NEXT QUARTER
$0.52
Range $0.52 – $0.52 · 1 analysts · +10% YoY
Next period, 1 analysts expect Innoviva Inc to earn $0.52 a share (range $0.52 – $0.52), versus $0.47 a year earlier. Full-year consensus is $1.91, growing to $2.21 the year after.
REVENUE · NEXT QUARTER
$118.0M
Range $99.8M – $141.3M · 1 analysts · +3% YoY
Revenue is expected to reach $118.0M (range $99.8M – $141.3M), +3.0% year-over-year. Full-year consensus is $446.5M, rising to $488.7M next year.
Top analysts covering Innoviva Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on INVA.
#1
Raghuram Selvaraju
HC Wainwright & Co. · Rank #312
Buy
$46.00+115.9% to target
Overall win rate
36%
+ Follow
#2
Julian Harrison
BTIG
Buy
$42.00+97.1% to target
Coverage
—
+ Follow
#3
SS
Steve Seedhouse
Cantor Fitzgerald
Buy
$34.00+59.5% to target
Coverage
—
+ Follow
#4
TA
Trevor Allred
Oppenheimer
Buy
$35.00+64.2% to target
Coverage
—
+ Follow
#5
Louise Chen
Scotiabank
Buy
$55.00+158.1% to target
Coverage
—
+ Follow
INVA stock forecast FAQ
What is INVA's average 12-month price target?+
The 4 analysts with a live target average $34.75 for Innoviva Inc over the next 12 months, ranging from a $46.00 high to a $17.00 low.
Is INVA stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 0 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for INVA?+
The Street-high target is $46.00 (HC Wainwright & Co.), and the Street-low is $17.00 (Goldman Sachs). The average of all 4 active targets is $34.75.
How many Wall Street analysts cover INVA?+
4 analysts have an active rating on Innoviva Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering INVA?+
Among analysts who currently cover INVA, Raghuram Selvaraju of HC Wainwright & Co. has the strongest overall Quantellect track record (Rank #312). Their current call is Buy with a $46.00 target.
What is Innoviva Inc's projected EPS for next quarter?+
The consensus estimate is $0.52 per share (range $0.52 – $0.52) across 1 analysts. Full-year EPS is projected at $1.91, rising to $2.21 the following year.
How much revenue is Innoviva Inc expected to report next quarter?+
Consensus revenue is $118.0M (range $99.8M – $141.3M). Full-year revenue is projected at $446.5M, growing to $488.7M next year.
Have analysts been upgrading or downgrading INVA lately?+
As of Sep, 3 of 3 firms rate INVA a Buy (0 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their INVA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
